|
BIONATURE is a biomedical research and development Company founded in 2002, which seeks to identify new technologies that will enable the diagnosis, prevention and treatment of diseases that contribute to human aging.
The main focus is novel therapeutic and diagnostic technologies in the
following fields:
 Oncology, anti-tumor therapy
Chronic inflammatory conditions
Clinical diagnostics
Neuroprotective activities of natural and synthetic compounds
Pharmacogenomics
|
 |
 |
 |
|
 |
|
 |
|
LATEST PUBLICATIONS
Corticotropin releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. View |
|
 |
|
 |
|
|
|
|
|
 |
|
LATEST NEWS
In March 2007 Bionature entered into a Research Funding Agreement with Emergomed for the Neuroprotect project. View article |
|
|
|
|
|
|
